Effect of levamlodipine besylate on mild and moderate hypertension in the elderly

Objective:To observe the clinical efficacy and safety of levamlodipine besylate on mild and moderate hypertension in the elderly.Methods:A total of 160 patients with mild and moderate hypertension were randomly divided into research and control group.The research group was given levamlodipine besylate;the control group,amlodipine besylate,with a course of 8 weeks,respec-tively.Results:The total effective rates at the end of 4 and 8 weeks in the research group were 78.75% and 96.25%,higher than those(53.75% and 86.25%) in the control group(P0.05).In the research group,the systolic blood pressure decreased(29.0 ±3.2) mmHg and diastolic blood pressure decreased(15.3 ±2.3) mmHg;in the control group,(18.5±2.8) mmHg and(9.0±2.5) mmHg,with statistically significant differences(P 0.05).Conclusion:Levamlodipine besylate is an effective and safety drug for the treatment of mild and moder-ate hypertension in the elderly,which can protecte the heart function.